Loading...
NCH2 logo

thyssenkrupp nucera AG & Co. KGaAXTRA:NCH2 Stock Report

Market Cap €1.2b
Share Price
€9.37
n/a
1Y10.1%
7D2.2%
Portfolio Value
View

thyssenkrupp nucera AG & Co. KGaA

XTRA:NCH2 Stock Report

Market Cap: €1.2b

thyssenkrupp nucera KGaA (NCH2) Stock Overview

Engages in the development, engineering, procurement, commissioning, and licensing of electrolysis technologies in Germany, Saudi Arabia, Sweden, the United States, and internationally. More details

NCH2 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for NCH2 from our risk checks.

NCH2 Community Fair Values

Create Narrative

See what 42 others think this stock is worth. Follow their fair value or set your own to get alerts.

Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth

EBIT-margin trajectory: Historical: 2.3 % → 3.6 % (FY 22/23) ​, down to – 2 % (FY 23/24) ​, back to 3 % in Q1 24/25 ​ Forecast: Gradual recovery to 4–6 % by FY 25/26, reaching 6–8 % by FY 29/30 Revenue growth: Historical: + 70 % (FY 22/23) ​, + 30 % (FY 23/24) ​, + 27 % (Q1 24/25) ​ Forecast: ~ 15 % CAGR over the next five years (FY 24/25–29/30) Five-year share-price goal: Current fair value: € 8.5–9.0 per share Five-year target: € 14–15 per share (≈ 1.9 bn EUR market cap) Enterprise value (EV) outlook (DCF-based): Revenues rising to ~ 1.8 bn EUR by FY 29/30 EBIT of ~ 145 m EUR (8 % margin) → NOPAT ~ 102 m EUR FCF margin ~ 5 % → ~ 90 m EUR FCF Terminal-value multiple: EV/FCF = 15 → TV ~ 1.35 bn EUR Discounted EV: ≈ 1.18 bn EUR + net cash 0.69 bn EUR → ≈ 1.87 bn EUR → ~ 14.8 EUR/share Top risks: execution delays, margin pressure from competition, raw-material cost swings, subsidy uncertainty, heavy capex needs Narrative Outlook Over the next five years, thyssenkrupp nucera is poised to leverage its unique position at the intersection of mature Chlor-Alkali expertise and rapid Green-Hydrogen adoption. After a transitional phase in FY 23/24 with negative margins driven by upfront investments, the company’s shift toward series-manufactured AWE modules and high-growth project backlog supports a steady margin recovery.
View narrative
€14.4
FV
35.0% undervalued intrinsic discount
15.00%
Revenue growth p.a.
2.3k
users have viewed this narrative
3users have liked this narrative
1users have commented on this narrative
21users have followed this narrative

thyssenkrupp nucera AG & Co. KGaA Competitors

Price History & Performance

Summary of share price highs, lows and changes for thyssenkrupp nucera KGaA
Historical stock prices
Current Share Price€9.37
52 Week High€11.90
52 Week Low€6.86
Beta1.23
1 Month Change4.11%
3 Month Change12.56%
1 Year Change10.11%
3 Year Changen/a
5 Year Changen/a
Change since IPO-60.18%

Recent News & Updates

There's Reason For Concern Over thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) Price

Jan 15
There's Reason For Concern Over thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) Price

Recent updates

There's Reason For Concern Over thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) Price

Jan 15
There's Reason For Concern Over thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) Price

Analysts Just Slashed Their thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) EPS Numbers

Nov 28
Analysts Just Slashed Their thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) EPS Numbers

Are Investors Undervaluing thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) By 25%?

Nov 27
Are Investors Undervaluing thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) By 25%?

Is Now The Time To Look At Buying thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2)?

Nov 03
Is Now The Time To Look At Buying thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2)?

thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) 26% Share Price Surge Not Quite Adding Up

Oct 07
thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) 26% Share Price Surge Not Quite Adding Up

thyssenkrupp nucera KGaA (ETR:NCH2) Is Posting Healthy Earnings, But It Is Not All Good News

Aug 18
thyssenkrupp nucera KGaA (ETR:NCH2) Is Posting Healthy Earnings, But It Is Not All Good News

thyssenkrupp nucera AG & Co. KGaA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 16
thyssenkrupp nucera AG & Co. KGaA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Is It Too Late To Consider Buying thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2)?

Jul 30
Is It Too Late To Consider Buying thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2)?

Weekly Picks: 💸 SUN's Insurance Dividends, NCH2's Hydrogen Exposure, and TSLA's Robotic Inflection Point

Jul 02
Weekly Picks: 💸 SUN's Insurance Dividends, NCH2's Hydrogen Exposure, and TSLA's Robotic Inflection Point

Should You Be Adding thyssenkrupp nucera KGaA (ETR:NCH2) To Your Watchlist Today?

Jun 26
Should You Be Adding thyssenkrupp nucera KGaA (ETR:NCH2) To Your Watchlist Today?

Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth

EBIT-margin trajectory:Historical: 2.3 % → 3.6 % (FY 22/23) ​, down to – 2 % (FY 23/24) ​, back to 3 % in Q1 24/25 ​Forecast: Gradual recovery to 4–6 % by FY 25/26, reaching 6–8 % by FY 29/30
User avatar

Upcoming NEOM Project And SOEC Technology Will Strengthen Position In Green Hydrogen Market

Strategic partnerships and R&D investments in SOEC technology position thyssenkrupp nucera for growth and improved margins in the hydrogen industry.

thyssenkrupp nucera AG & Co. KGaA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Dec 20
thyssenkrupp nucera AG & Co. KGaA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) Popularity With Investors Is Clear

Dec 10
thyssenkrupp nucera AG & Co. KGaA's (ETR:NCH2) Popularity With Investors Is Clear

Earnings Miss: thyssenkrupp nucera AG & Co. KGaA Missed EPS By 15% And Analysts Are Revising Their Forecasts

Aug 16
Earnings Miss: thyssenkrupp nucera AG & Co. KGaA Missed EPS By 15% And Analysts Are Revising Their Forecasts

Are Investors Undervaluing thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) By 41%?

May 08
Are Investors Undervaluing thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) By 41%?

Is thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) Trading At A 39% Discount?

Jan 07
Is thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) Trading At A 39% Discount?

Shareholder Returns

NCH2DE ConstructionDE Market
7D2.2%1.4%0.3%
1Y10.1%136.6%5.6%

Return vs Industry: NCH2 underperformed the German Construction industry which returned 136.6% over the past year.

Return vs Market: NCH2 exceeded the German Market which returned 5.6% over the past year.

Price Volatility

Is NCH2's price volatile compared to industry and market?
NCH2 volatility
NCH2 Average Weekly Movement5.2%
Construction Industry Average Movement6.1%
Market Average Movement5.4%
10% most volatile stocks in DE Market13.4%
10% least volatile stocks in DE Market2.6%

Stable Share Price: NCH2 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: NCH2's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1960963Werner Ponikwarthyssenkrupp-nucera.com

thyssenkrupp nucera AG & Co. KGaA engages in the development, engineering, procurement, commissioning, and licensing of electrolysis technologies in Germany, Saudi Arabia, Sweden, the United States, and internationally. It operates through the Chlor-Alkali (CA) and Green Hydrogen (gH2) segments. The company is involved in the development, planning, and construction of new-build electrolysis plants for producing green hydrogen for industrial applications; provision of services for chlor-alkali electrolysis, such as planning and construction of new plants.

thyssenkrupp nucera AG & Co. KGaA Fundamentals Summary

How do thyssenkrupp nucera KGaA's earnings and revenue compare to its market cap?
NCH2 fundamental statistics
Market cap€1.18b
Earnings (TTM)-€7.40m
Revenue (TTM)€730.20m
1.6x
P/S Ratio
-159.9x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NCH2 income statement (TTM)
Revenue€730.20m
Cost of Revenue€622.00m
Gross Profit€108.20m
Other Expenses€115.60m
Earnings-€7.40m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

May 12, 2026

Earnings per share (EPS)-0.059
Gross Margin14.82%
Net Profit Margin-1.01%
Debt/Equity Ratio0%

How did NCH2 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/15 21:47
End of Day Share Price 2026/02/13 00:00
Earnings2025/12/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

thyssenkrupp nucera AG & Co. KGaA is covered by 16 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Virginia Sanz de Madrid GrossBanco Santander
James CarmichaelBerenberg
Alexander JonesBofA Global Research